TAS 750600 TAS new contract copy testing of messages in direct-to-consumer (DTC) promotion of prescription drugs

Ended Indefinite Delivery Contract Awarded Last action

Contract number
HHSF223201110011I
Awardee
Awarding agency
Task orders
5 $393,625 obligated

Award facts

Combined order value
$393,625 Current and potential, with all options
Last date to order 100% complete
Award type
Single award
Who can order
Only the awarding agency
Set-aside
Competitive 8(a)
Competition
Competed under SAP · 4 offers Simplified Acquisition
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

Written by GovTribe AI ·

This indefinite delivery contract was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Sensis Inc., a single-award 8(a) small disadvantaged business. The contract's purpose is to provide copy testing services for direct-to-consumer (DTC) promotion of prescription drugs, with a total ceiling value of $0.

To date, the FDA has issued five firm-fixed-price delivery orders under this IDC, with a combined ceiling value of approximately $393,792. The task orders cover copy testing of DTC advertisements for specific pharmaceutical products, including Xarelto, Entresto, and an unnamed "medium incidence medical condition." The work is to be performed at locations in Silver Spring, MD and Los Angeles, CA, with periods of performance ranging from 2014 to 2016. Sensis Inc., an integrated marketing agency with experience supporting federal public health campaigns, is the prime contractor delivering these copy testing services to the FDA.

Task orders

Task order Ordering agency Obligated Awarded
Entresto copy test HHSF22301004T Food and Drug Administration $86,640
Task order for the contractor for xarelto copy-testing study HHSF22301005T Food and Drug Administration $86,640
Contractor support to assist with one copy test HHSF22301001T Food and Drug Administration $68,678
Closely associated: task order #2:copy testing of 60-second DTC television ad for a medium incidence medical condition HHSF22301003T Food and Drug Administration $75,833
Task order for copy testing of messages in DTC promotion of prescription drugs HHSF22301002T Food and Drug Administration $75,833

Transactions

Action Obligated Date
Exercise an Option 8 $0
Exercise an Option 7 · Exercise option year 3 $0
Exercise an Option 6 $0
Exercise an Option 5 · Exercise option year 2 $0
Other Administrative Action 4 · "closely associated" TAS 750600 TAS new contract copy testing of messages in direct-to-consumer (DTC) promotion of prescription drugs $0
Exercise an Option 3 $0
Other Administrative Action 2 · Closely associated: copy testing of messages in direct-to-consumer (DTC) promotion of prescription drugs $0
Other Administrative Action 1 $0
Original award $0

Quick answers

Who was awarded contract HHSF223201110011I?

HHSF223201110011I was awarded to Sensis Inc. by Food and Drug Administration (Department of Health and Human Services) on July 12, 2011.

How much is contract HHSF223201110011I worth?

Orders under HHSF223201110011I have obligated $393,625.

How many orders have been placed under contract HHSF223201110011I?

5 orders have been placed under HHSF223201110011I, the latest on July 12, 2016.

Who can order from contract HHSF223201110011I?

HHSF223201110011I is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract HHSF223201110011I competed?

The extent of competition for HHSF223201110011I was competed under sap. The government received 4 offers. It was set aside: Competitive 8(a).

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV
Try for free Login